Commercial Intelligence
For Manufacturers

Commercial and tender intelligence for manufacturers and distributors entering or growing in Central America.

Pharmacy volume

Where the retail channel is largest

Hover over a country to see its pharmacy volume and imports.Tap a country to see its pharmacy volume and imports.

LowerHigher

Market Volume

A USD$4.85B pharmacy market — and a USD$6.02B medicines import basket across SE-COMISCA

Central America and the Dominican Republic form a multi-billion-dollar pharmaceutical bloc. Pharmacy sales and HS 30 imports are separate lenses on scale: one is retail-channel volume, the other is a partial trade basket that includes hospital, industrial, and re-export flows.

  • Pharmacy volume

    US$4.85B

    Mar 2024 · +6.6% YoY

  • HS 30 pharma imports

    US$6.02B

    SE-COMISCA medicines basket — not retail sales

  • Audited total market

    US$6.02B

    CADR retail + non-retail (~USD$6.02B)

  • India share of HS 30

    7.0%

    US$419.5M of the USD$6.02B import basket

Pharmacy volume versus HS 30 imports

Pharmacy sales are a retail reference and are not added to imports. Costa Rica’s HS 30 figure exceeds pharmacy sales because of hospital, industrial, and re-export flows.

China and India origin shares

India HS 30 is importer-reported value as a share of the SE-COMISCA medicines basket. China HS 30 is reported where a Comtrade figure exists; pale bars are 2023 top-10 ceilings. China HS 9018 is the medical-instruments share.

China in HS 9018 instruments

Weighted China share is 11.2% (US$149.9M of US$1.34B). Dominican Republic leads at 30.1%; Costa Rica is only 4.2% despite the largest instrument import bill.

SE-COMISCA country file

Values in US$ millions except percentages. India and China HS 30 shares use importer-reported Comtrade; volume columns use the regional briefing table.

SE-COMISCA country file
CountryPharmacyYoYHS 30India HS 30China HS 30HS 9018China HS 9018
Dominican RepublicPROMESE/CAL and SNSUS$1.14B-2.0%US$1.01BUS$102.0M10.1% · 2023Below top 10< 3.5% · 2023US$114.3MUS$34.4M30.1%
GuatemalaMSPAS and IGSSUS$968M+9.3%US$1.12BUS$115.0M10.3% · 2023US$27.0M2.4% · 2025US$122.0MUS$29.4M24.1%
Costa RicaCCSSUS$731M+16.3%US$1.11BUS$31.0M2.8% · 2023US$21.8M2.0% · 2024US$779.7MUS$32.7M4.2%
HondurasSESAL and IHSSUS$665M+9.3%US$757.0MUS$43.0M5.7% · 2023Below top 10< 4.8% · 2023US$40.3MUS$11.2M27.8%
El SalvadorMINSAL and ISSSUS$496M+7.1%US$646.5MUS$39.0M6.0% · 2023Below top 10< 2.6% · 2023US$76.4MUS$18.5M24.2%
PanamaMINSA and CSSUS$486M+3.4%US$824.3MUS$22.5M2.7% · 2025Below top 10< 2.3% · 2023US$138.6MUS$11.6M8.4%
NicaraguaMINSAUS$358M+9.6%US$550.7MUS$67.0M12.2% · 2023US$23.3M4.2% · 2024US$66.4MUS$12.4M18.6%
SE-COMISCAUS$4.85B+6.6%US$6.02BUS$419.5MReported in GT, CR, NIUS$1.34BUS$149.9M · 11.2%

Belize is a COMISCA member but is omitted from the source import table. HS 30 and HS 9018 are partial baskets. Gross imports are not accessible demand for any single origin. Sources: SE-COMISCA import briefing, UN Comtrade HS 30.

Market Opportunity

Real-time pharmaceutical procurement intelligence across Central America — capture deals before your competitors

The Central American pharmaceutical market is fragmented across four national procurement systems: Costa Rica's SICOP, Guatemala's Guatecompras, Panama's PanamaCompra, and Honduras's Sistema de Compras Públicas. Today, these systems operate in silos. Suppliers are forced to monitor each platform manually, creating delays, missed opportunities, and lost market share. Tendrium centralizes pharmaceutical and medical procurement across these markets in a single, real-time intelligence platform. You don't hunt for tenders — they find you.

The Market Gap

  • Fragmentation

    Each Central American country publishes public procurement data, but no unified access exists

  • Speed

    Manual monitoring creates days of lag; competitors with automated systems move first

  • Data Density

    Procurement systems publish raw lists; they don't surface competitive intelligence, price trends, or institutional buying patterns

  • Scale

    2,400+ tenders monthly in Costa Rica alone; 8,000+ across Central America — impossible to monitor manually

Why Now

  • Costa Rica's SICOP publishes open tender and pricing data (General Public Procurement Law No. 9986)
  • Guatemala, Panama, and Honduras are moving toward open procurement (OCDS compliance underway)
  • Regional consolidation of multinational suppliers is accelerating; bidding strategies require cross-country visibility
  • Pharmaceutical margins are compressing; winning bids requires real-time market insight, not weekly email summaries

Core Capabilities

Everything you need to win in Central American pharmaceutical markets

  • Real-Time Tender Matching

    • Automatically scan 8,000+ monthly tenders across Central America
    • Match tenders to your product portfolio by pharmaceutical name, UNSPSC category, or bioequivalent variant
    • Receive instant alerts when a match occurs via email or WhatsApp
    • Filter by institution, procurement type, and budget range
  • Competitive Intelligence

    • See who won the last 12 months of awarded contracts in your category
    • Track competitor bid frequency and awarded price ranges
    • Identify institutional buying patterns (CAJA renews antiretroviral supply Q1)
    • Monitor price trends to know when institutional budgets allow premium pricing
  • Market Coverage

    • Costa Rica: 2,400+ active tenders; 90%+ from CAJA; historical data from 2020
    • Guatemala, Panama, Honduras: data ingestion pipelines live; coming 2026
    • Full tender depth: title, institution, type, budget, deadline, awarded supplier, price
  • Strategic Product Tracking

    • Automatic watchlist for 172 bioequivalent pharmaceutical variants
    • Automatic watchlist for 404 difficult-to-source supply items (high margin, low competition)
    • Personalized alerts so you never miss niche market opportunities

Business Outcomes

Outcomes we design Tendrium to support

  • 25–40%

    Modeled potential win-rate lift — not a guaranteed result

  • 15–20h

    Illustrative weekly hours saved per sales team

  • ±5%

    Modeled margin stability per bid

  • 30–50%

    Modeled revenue potential from expansion — not a guaranteed result

  • Faster Deal Capture

    Before
    Sales teams check SICOP weekly, missing bids closed mid-week. 30% of relevant tenders are discovered post-close.
    With Tendrium
    Alerts fire within 1 hour of publication. Zero missed bids in your category. Average time from alert to bid submission: 2 days.
    Result
    Modeled potential: faster speed-to-bid. Published percentages are scenarios, not guaranteed results.
  • Reduced Sales Overhead

    Before
    Manual monitoring across 4 national portals. Sales reps hunting data instead of closing deals.
    With Tendrium
    Eliminate manual SICOP monitoring. Consolidate 4 portals into 1 dashboard with zero context switching.
    Result
    Illustrative: hours returned from manual portal monitoring to commercial work — not a guaranteed FTE saving.

Evaluate your portfolio for Central America

Share your molecules, target countries, and timeline. We reply within 48 hours with a proposed next step.

Evaluate my portfolio